For the quarter ending 2025-11-30, ORCL had $8,796M increase in cash & cash equivalents over the period. -$9,967M in free cash flow.
| Cash Flow | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 |
|---|---|---|---|---|
| Net income | 6,135 | 2,927 | 3,427 | 2,936 |
| Depreciation | 1,704 | 1,351 | 1,152 | 1,003 |
| Amortization of intangible assets | 406 | 420 | 544 | 548 |
| Deferred income taxes | -183 | 515 | -540 | -496 |
| Stock-based compensation | 1,156 | 1,124 | 1,300 | 1,198 |
| Other, net | - | -164 | -245 | -124 |
| Gains from investments and other, net | 2,227 | - | - | - |
| Increase in trade receivables, net | 655 | 245 | 341 | -139 |
| Decrease in prepaid expenses and other assets | -1,226 | -59 | 337 | 73 |
| Decrease in accounts payable and other liabilities | -1,032 | -334 | 25 | 510 |
| Decrease in income taxes payable | -2,217 | -391 | 563 | 463 |
| Increase in deferred revenues | -2,083 | 2,550 | 119 | -419 |
| Net cash provided by operating activities | 2,066 | 8,140 | 6,157 | 5,933 |
| Purchases of marketable securities and other investments | 163 | 471 | 434 | 202 |
| Proceeds from sales and maturities of marketable securities and other investments | 4,482 | 255 | 332 | 88 |
| Acquisitions, net of cash acquired | - | - | 0 | 0 |
| Capital expenditures | 12,033 | 8,502 | 9,080 | 5,862 |
| Net cash used for investing activities | -7,714 | -8,718 | -9,182 | -5,976 |
| Payments for repurchases of common stock | 0 | 95 | 150 | 150 |
| Proceeds from issuances of common stock | 138 | 1,170 | 133 | 213 |
| Shares repurchased for tax withholdings upon vesting of restricted stock-based awards | 92 | 17 | 0 | 2 |
| Payments of dividends to stockholders | 1,435 | 1,413 | 1,403 | 1,119 |
| Repayments of commercial paper, net | - | -158 | - | - |
| Proceeds from issuances of (repayments of) commercial paper, net | - | - | 2,285 | 0 |
| Proceeds from (repayments of) commercial paper and other short-term financing, net | -886 | - | - | - |
| Proceeds from issuances of term loan credit agreements | - | 0 | - | - |
| Proceeds from issuances of senior notes and term loan credit agreements, net of issuance costs | 17,880 | - | 0 | 7,711 |
| Repayments of senior notes, term loan credit agreements and other borrowings | 1,070 | 1,052 | 6,070 | 71 |
| Other financing activities, net | -2,058 | 1,855 | 1,391 | -23 |
| Net cash provided by (used for) financing activities | 14,487 | 210 | -3,814 | 6,559 |
| Effect of exchange rate changes on cash and cash equivalents | -43 | 27 | 219 | -51 |
| Net increase in cash and cash equivalents | 8,796 | -341 | -6,620 | 6,465 |
| Cash and cash equivalents at beginning of period | 10,445 | 10,786 | 17,406 | 10,941 |
| Cash and cash equivalents at end of period | 19,241 | 10,445 | 10,786 | 17,406 |
ORACLE CORP (ORCL)
ORACLE CORP (ORCL)